The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERON PHARMA INC | COM | 00434H108 | 91,455 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 143,924 | 1,050,000 | SH | OTR | 1,050,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 40,101 | 550,000 | SH | OTR | 550,000 | 0 | 0 | ||
ALPHABET INC | CAP STK CL C | 02079K107 | 480,942 | 464,405 | SH | OTR | 464,405 | 0 | 0 | ||
ALTABA INC | COM | 021346101 | 1,599,568 | 27,607,317 | SH | OTR | 27,607,317 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 47,635 | 3,500,000 | SH | OTR | 3,500,000 | 0 | 0 | ||
ANHEUSER BUSCH INBEV SA/NV | SPONSORED ADR | 03524A108 | 18,153 | 275,843 | SH | OTR | 275,843 | 0 | 0 | ||
ANTHEM INC | COM | 036752103 | 275,762 | 1,050,000 | SH | OTR | 1,050,000 | 0 | 0 | ||
APTINYX INC | COM | 03836N103 | 11,082 | 670,000 | SH | OTR | 670,000 | 0 | 0 | ||
ARRAY BIOPHARMA INC | COM | 04269X105 | 81,938 | 5,750,000 | SH | OTR | 5,750,000 | 0 | 0 | ||
ARRIS INTL INC | SHS | G0551A103 | 109,441 | 3,580,000 | SH | OTR | 3,580,000 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 18,630 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 93,931 | 1,499,297 | SH | OTR | 1,499,297 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 7,917 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 147,552 | 3,885,000 | SH | OTR | 3,885,000 | 0 | 0 | ||
AVISTA CORP | COM | 05379B107 | 2,672 | 62,900 | SH | OTR | 62,900 | 0 | 0 | ||
AVROBIO INC | COM | 05455M100 | 10,823 | 650,000 | SH | OTR | 650,000 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 2,920 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
BEMIS INC | COM | 081437105 | 14,512 | 316,160 | SH | OTR | 316,160 | 0 | 0 | ||
BOOKING HLDGS INC | COM | 09857L108 | 285,030 | 165,482 | SH | OTR | 165,482 | 0 | 0 | ||
BROOKFIELD PPTY PARTNERS L P | UNIT LTD PARTN | G16249107 | 33,449 | 2,075,000 | SH | OTR | 2,075,000 | 0 | 0 | ||
CHARTER COMMUNICATIONS INC N | CL A | 16119P108 | 307,905 | 1,080,481 | SH | OTR | 1,080,481 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 15,820 | 1,450,000 | SH | OTR | 1,450,000 | 0 | 0 | ||
CIGNA CORP NEW | COM | 125523100 | 200,366 | 1,055,000 | SH | OTR | 1,055,000 | 0 | 0 | ||
CITRIX SYS INC | COM | 177376100 | 150,435 | 1,468,234 | SH | OTR | 1,468,234 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 17,960 | 1,000,000 | SH | OTR | 1,000,000 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | NOTE 1.250% 5/0 | 189464AC4 | 10,475 | 14,750,000 | PRN | OTR | 14,750,000 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 19,289 | 1,155,000 | SH | OTR | 1,155,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 2,860 | 95,365 | SH | OTR | 95,365 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 35,713 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
CVS HEALTH CORP | COM | 126650100 | 60,934 | 930,000 | SH | OTR | 930,000 | 0 | 0 | ||
DELL TECHNOLOGIES INC | CL C | 24703L202 | 174,567 | 3,572,062 | SH | OTR | 3,572,062 | 0 | 0 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | 18,300 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 65,518 | 925,000 | SH | OTR | 925,000 | 0 | 0 | ||
EQUIFAX INC | COM | 294429105 | 199,819 | 2,145,594 | SH | OTR | 2,145,594 | 0 | 0 | ||
EQUINIX INC | COM PAR $0.001 | 29444U700 | 391,656 | 1,110,892 | SH | OTR | 1,110,892 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 39,340 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
FACEBOOK INC | CL A | 30303M102 | 399,975 | 3,051,148 | SH | OTR | 3,051,148 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 28,226 | 2,200,000 | SH | OTR | 2,200,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 34,710 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
FIDELITY NATL INFORMATION SV | COM | 31620M106 | 194,779 | 1,899,355 | SH | OTR | 1,899,355 | 0 | 0 | ||
GENERAL DYNAMICS CORP | COM | 369550108 | 255,967 | 1,628,186 | SH | OTR | 1,628,186 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 59,523 | 1,450,000 | SH | OTR | 1,450,000 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 43,717 | 2,381,119 | SH | OTR | 1 | 2,381,119 | 0 | 0 | |
IHS MARKIT LTD | SHS | G47567105 | 283,983 | 5,920,016 | SH | OTR | 5,920,016 | 0 | 0 | ||
INDUSTRIAL LOGISTICS PPTYS T | COM SHS BEN INT | 456237106 | 12,009 | 610,545 | SH | OTR | 610,545 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 2,848 | 250,000 | SH | OTR | 250,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 50,666 | 5,725,000 | SH | OTR | 5,725,000 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 373,987 | 3,219,308 | SH | OTR | 3,219,308 | 0 | 0 | ||
LIBERTY GLOBAL PLC | SHS CL A | G5480U104 | 127,452 | 5,972,437 | SH | OTR | 5,972,437 | 0 | 0 | ||
LIBERTY GLOBAL PLC | SHS CL C | G5480U120 | 101,904 | 4,937,202 | SH | OTR | 4,937,202 | 0 | 0 | ||
MELLANOX TECHNOLOGIES LTD | SHS | M51363113 | 8,776 | 95,000 | SH | OTR | 95,000 | 0 | 0 | ||
MICROSOFT CORP | COM | 594918104 | 262,952 | 2,588,874 | SH | OTR | 2,588,874 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 55,146 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
MYOKARDIA INC | COM | 62857M105 | 78,190 | 1,600,278 | SH | OTR | 1,600,278 | 0 | 0 | ||
NOVOCURE LTD | ORD SHS | G6674U108 | 41,850 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
NXP SEMICONDUCTORS N V | COM | N6596X109 | 39,205 | 535,000 | SH | OTR | 535,000 | 0 | 0 | ||
ORBOTECH LTD | ORD | M75253100 | 30,290 | 535,721 | SH | OTR | 535,721 | 0 | 0 | ||
PANDORA MEDIA INC | COM | 698354107 | 74,468 | 9,205,000 | SH | OTR | 9,205,000 | 0 | 0 | ||
PFENEX INC | COM | 717071104 | 1,914 | 600,000 | SH | OTR | 600,000 | 0 | 0 | ||
PLAYA HOTELS & RESORTS NV | SHS | N70544106 | 220,064 | 30,606,930 | SH | OTR | 30,606,930 | 0 | 0 | ||
PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 9,587 | 350,000 | SH | OTR | 350,000 | 0 | 0 | ||
PROGENICS PHARMACEUTICALS IN | COM | 743187106 | 17,643 | 4,200,820 | SH | OTR | 4,200,820 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 14,804 | 2,199,674 | SH | OTR | 2,199,674 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 24,024 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | NOTE 3.000% 8/1 | 69366JAB7 | 23,602 | 24,130,000 | PRN | OTR | 24,130,000 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 14,688 | 2,400,000 | SH | OTR | 2,400,000 | 0 | 0 | ||
RA MED SYS INC | COM | 74933X104 | 305 | 38,313 | SH | OTR | 38,313 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 33,692 | 2,043,149 | SH | OTR | 2,043,149 | 0 | 0 | ||
READY CAP CORP | COM | 75574U101 | 30,471 | 2,203,239 | SH | OTR | 2,203,239 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 39,270 | 700,000 | SH | OTR | 700,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 38,316 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
SANOFI | RIGHT 12/31/2020 | 80105N113 | 3,277 | 6,827,805 | SH | OTR | 6,827,805 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 69,843 | 640,000 | SH | OTR | 640,000 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 18,357 | 2,425,000 | SH | OTR | 2,425,000 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 15,204 | 87,000 | SH | OTR | 87,000 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 1,873,150 | 7,495,000 | SH | Call | OTR | 7,495,000 | 0 | 0 | |
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 173,195 | 693,000 | SH | Put | OTR | 693,000 | 0 | 0 | |
SYNTHORX INC | COM | 87167A103 | 6,710 | 386,092 | SH | OTR | 386,092 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 126,225 | 1,700,000 | SH | OTR | 1,700,000 | 0 | 0 | ||
TILRAY INC | COM CL 2 | 88688T100 | 162,074 | 2,479,515 | SH | OTR | 2,479,515 | 0 | 0 | ||
TRANSLATE BIO INC | COM | 89374L104 | 3,750 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
TRANSUNION | COM | 89400J107 | 299,264 | 5,268,739 | SH | OTR | 5,268,739 | 0 | 0 | ||
TYME TECHNOLOGIES INC | COM | 90238J103 | 1,110 | 300,857 | SH | OTR | 300,857 | 0 | 0 | ||
VANECK VECTORS ETF TR | SEMICONDUCTOR ET | 92189F676 | 187,652 | 2,150,000 | SH | Put | OTR | 2,150,000 | 0 | 0 | |
VERISK ANALYTICS INC | COM | 92345Y106 | 157,148 | 1,441,194 | SH | OTR | 1,441,194 | 0 | 0 | ||
VISA INC | COM CL A | 92826C839 | 306,065 | 2,319,726 | SH | OTR | 2,319,726 | 0 | 0 | ||
VOYA FINL INC | COM | 929089100 | 7,426 | 185,000 | SH | OTR | 185,000 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 8,546 | 909,158 | SH | OTR | 909,158 | 0 | 0 | ||
WABTEC CORP | COM | 929740108 | 388,557 | 5,531,059 | SH | OTR | 5,531,059 | 0 | 0 | ||
ZAFGEN INC | COM | 98885E103 | 8,786 | 1,775,000 | SH | OTR | 1,775,000 | 0 | 0 | ||
ZEALAND PHARMA A S | SPONSORED ADR | 98920Y304 | 10,449 | 900,000 | SH | OTR | 900,000 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 74,761 | 2,050,500 | SH | OTR | 2,050,500 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 23,121 | 1,575,000 | SH | OTR | 1,575,000 | 0 | 0 |